循环干预改善了帕金森病并可能减缓疾病的进展:一项十年的回顾性研究
Gregory Willis1, Takuyuki Endo2, Murray Waldman3
1The Bronowski Clinic, The Bronowski Institute of Behavioral Neuroscience, Woodend, VIC 3442, Australia.
Brain sciences
|January 8, 2025
概括
照明治疗 (LT) 改善了帕金森病 (PD) 的前兆和运动症状在十年内. 持续的每日LT使用有助于保持改善,这表明在减缓PD进展方面发挥了作用.
科学领域:
- 神经科学是一个神经科学.
- 时间生物学 时间生物学
- 运动障碍 运动障碍
背景情况:
- 循环节律扰乱越来越多地与帕金森病 (PD) 的病因和进展有关.
- 失眠和疲劳等突发症状显著损害了PD患者的生活质量.
- 对PD的光疗 (LT) 的长期研究是有限的.
研究的目的:
- 研究照明治疗 (LT) 对帕金森病 (PD) 昼夜功能和症状的长期影响.
- 评估LT对PD患者在10年的影响.
主要方法:
- 一项探索性研究追踪了LT在10年中的影响.
- 在每天接受LT的参与者中监测昼夜功能和PD症状.
主要成果:
- 循环时刻的症状随着LT的启动而迅速且一致地改善.
- 经过1.2年的长期治疗后,观察到运动功能的改善.
- 持续的症状改善 (运动和前进性) 维持在患者遵守的情况下.
结论:
- 症状的顺序改善反映了PD的缓慢退行过程和LT的修复作用.
- 研究结果支持这样一个假设:早期的昼夜干扰会增加PD的风险.
- 通过调节昼夜功能,LT提供了一种微创的方法来减缓PD的进展.
相关概念视频
Parkinson's Disease: Treatment
215
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
215
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
41
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
41
Parkinson's Disease: Overview
472
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
472
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Management of Insomnia
230
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
230


